Skip to Main Content

Paper Details

Longitudinal molecular trajectories of diffuse glioma in adults.
Nature
298
2019
IDH mutation, chromosome arms 1p/19q, diffuse glioma, driver genes, glioma, glioma subtypes, gliomas, patients, tumour
Author NameAffiliation
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Kenneth AldapeCenter for Cancer Research, National Cancer Institute
Don??t Alp??rCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Don??t Alp??rSemmelweis University
Pratiti BandopadhayayDana-Farber Cancer Institute
Pratiti BandopadhayayBroad Institute
Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Rameen BeroukhimBroad Institute
Rameen BeroukhimDana-Farber Cancer Institute
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockMedical University of Vienna
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockMedical University of Vienna
Priscilla K BrastianosMassachusetts General Hospital
Daniel J BratNorthwestern University Feinberg School of Medicine
Joseph F CostelloUniversity of California San Francisco
Gaetano FinocchiaroFondazione IRCCS Istituto Neurologico Besta
Gaetano FinocchiaroFondazione IRCCS Istituto Neurologico Besta
Pim J FrenchErasmus MC - University Medical Center Rotterdam
Antonio IavaroneColumbia University Medical Center
Antonio IavaroneInstitute for Cancer Genetics, Columbia University Medical Center
Antonio IavaroneColumbia University Medical Center
Antonio IavaroneColumbia University Medical Center
Antonio IavaroneColumbia University Medical Center
Antonio IavaroneInstitute for Cancer Genetics, Columbia University Medical Center
Hoon Kim
Peter LichterHeidelberg Center for Personalized Oncology, German Cancer Research Center (DKFZ)
Peter LichterHeidelberg Center for Personalized Oncology, German Cancer Research Center (DKFZ)
Keith L LigonBroad Institute
Keith L LigonDana-Farber Cancer Institute
Tathiane M MaltaHenry Ford Cancer Institute
Tali MazorUniversity of California San Francisco
Annette M MolinaroUniversity of California San Francisco
Do-Hyun NamSungkyunkwan University School of Medicine, Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSungkyunkwan University School of Medicine, Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Ho-Keung NgThe Chinese University of Hong Kong, Prince of Wales Hospital
Ho-Keung NgThe Chinese University of Hong Kong, Prince of Wales Hospital
Houtan NoushmehrHenry Ford Cancer Institute
Houtan NoushmehrHenry Ford Cancer Institute
Chul-Kee ParkSeoul National University College of Medicine, Seoul National University Hospital
Laila M PoissonHenry Ford Cancer Institute
Raul RabadanColumbia University Medical Center
Raul RabadanColumbia University
Ganesh RaoThe University of Texas MD Anderson Cancer Center
Guido ReifenbergerInstitute of Neuropathology, Heinrich Heine University Dusseldorf
Jason K SaInstitute for Refractory Cancer Research, Samsung Medical Center
Michael SchusterCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
  • 1 - 50

Datasets